Effect of growth hormone,hyperbaric oxygen and combined therapy on the gastric serosa

被引:0
作者
Gokhan Adas
Mine Adas
Soykan Arikan
Ahu Kemik Sarvan
Akin Savas TokluDepartment of Underwater and Hyperbaric Medicine
Selva Mert
Gul Barut
Sedat Kamali
Bora Koc
Firat Tutal
机构
[1] Department of Surgery,Okmeydani training and Research Hospital,34384 Istanbul,Turkey
[2] Department of Endocrinology,Okmeydani Training and Research Hospital,34384 Istanbul,Turkey
[3] Department of Surgery,Bakirkoy Dr.Sadi Konuk Training and Research Hospital,34147 Istanbul,Turkey
[4] Department of Pathology,Haseki Training and Research Hospital,34096 Istanbul,Turkey
[5] Department of Underwater and Hyperbaric Medicine,Istanbul Faculty of Medicine,34091 Istanbul,Turkey
[6] Department of Biochemistry,Istanbul Faculty of Medicine,34091 Istanbul,Turkey
[7] Department of Surgery,Istanbul Training and Research Hospital,34098 Istanbul,Turkey
关键词
Growth hormone; Hyperbaric oxygen; Neomucosa; Short bowel syndrome; Hypoxia;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
1002 ; 100201 ;
摘要
AIM:To investigate the role of growth hormone(GH),hyperbaric oxygen therapy(HBOT) and combined therapy on the intestinal neomucosa formation of the gastric serosa.METHODS:Forty-eight male Wistar-albino rats,weighing 250-280 g,were used in this study.The rats were divided into four groups(n = 12):Group 1,control,gastric serosal patch;Group 2,gastric serosal patch + GH;Group 3,gastric serosal patch + HBOT;and Group 4,gastric serosal patch + GH + HBOT.Abdominal access was achieved through a midline incision,and after the 1-cm-long defect was created in the jejunum,a 1 cm × 1 cm patch of the gastric corpus was anastomosed to the jejunal defect.Venous blood samples were taken to determine the insulin-like growth factor 1(IGF-1) and insulin-like growth factor binding protein 3(IGFBP-3) basal levels.HBOT was performed in Groups 3 and 4.In Groups 2 and 4,human GH was given subcutaneously at a dose of 2 mg per kg/d for 28 d,beginning on the operation day.All animals were sacrificed 60 d after surgery.The jejunal segment and the gastric anastomotic area were excised for histological examination.The inflammatory process,granulation,collagen deposition and fibroblast activity at the neomucosa formation were studied and scored.Additionally,the villus density,villus height,and crypt depth were counted and recorded.The measurements of villus height and crypt depth were calculated with an ocular micrometer.New vessel growth was determined by calculatingeach new vessel in a 1 mm 2 area.RESULTS:In the histological comparison of groups,no significant differences were observed between the control group and Groups 2 and 3 with respect to epithelialization,granulation,fibroblastic activity and the inflammatory process,but significant differences were present between the control group and all others groups(Groups 2-4) with respect to angiogenesis(P < 0.01) and collagen deposition(P < 0.05,P < 0.01).Significant differences between the control group and Group 4 were also observed with respect to epithelialization and fibroblastic activity(P < 0.01 and P < 0.05,respectively).There were significant differences in villus density in all of groups compared with the control group(P < 0.05).Crypt depth was significantly greater in Group 4 than in the control group(P < 0.05),but no other groups had deeper crypts.However,villus height was significantly longer in Groups 2 and 4 than in the control group(P < 0.05).The comparison of groups revealed,significant difference between control group and Groups 2 and 4) with respect to the levels of IGF-1 and IGFBP-3(P < 0.01) 3 wk after the operation.CONCLUSION:HBOT or GH and combined therapy augmented on neomucosal formation.The use of combined therapy produced a synergistic effect on the histological,morphological and functional parameters.
引用
收藏
页码:2904 / 2912
页数:9
相关论文
共 17 条
  • [1] Effect of bowel rehabilitative therapy on structural adaptation of remnant small intestine: animal experiment[J]. Xin Zhou1;Yuan Xin Li2;Ning Li2;Jie Shou Li2 1Department of General Surgery, Medical School, Nanjing University, Nanjing 210093. Jiangsu Province. China 2Research Institute of General Hospital. Chinese PLA General Hospital of Nanjing Military Area, Nanjing 210002. Jiangsu Province. China.World Journal of Gastroenterology. 2001(01)
  • [2] Tissue-Engineered Small Intestine and Stomach Form from Autologous Tissue in a Preclinical Large Animal Model
    Sala, Frederic G.
    Kunisaki, Shaun M.
    Ochoa, Erin R.
    Vacanti, Joseph
    Grikscheit, Tracy C.
    [J]. JOURNAL OF SURGICAL RESEARCH, 2009, 156 (02) : 205 - 212
  • [3] Combination of Fibrin Glue with Growth Hormone Augments Healing of Incomplete Intestinal Anastomoses in a Rat Model of Intra-Abdominal Sepsis: A Dynamic Study[J] . Yousheng Li,Yang Bao,Tao Jiang,Li Tan,Fangnan Liu,Jieshou Li.Investigative Surgery . 2007 (5)
  • [4] Short bowel syndrome
    Parekh N.R.
    Steiger E.
    [J]. Current Treatment Options in Gastroenterology, 2007, 10 (1) : 10 - 23
  • [5] Hyperbaric oxygen as a treatment for malabsorption in a radiation-damaged short bowel
    Huddy, James E.
    Patel, Pritash
    Johnson, Matthew W.
    Hamilton-Farrell, Martin R.
    Ede, Roland J.
    Sanderson, Jeremy D.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (06) : 685 - 688
  • [6] Treatment of Adult Short Bowel Syndrome With Recombinant Human Growth Hormone: A Review of Clinical Studies[J] . Bernard Messing,Sandra Blethen,John K. DiBaise,Laura E. Matarese,Ezra Steiger.Journal of Clinical Gastroenterology . 2006
  • [7] An Evidence-Based Appraisal of the Use of Hyperbaric Oxygen on Flaps and Grafts[J] . H I. F. Friedman,M Fitzmaurice,J F. Lefaivre,T Vecchiolla,D Clarke.Plastic and Reconstructive Surgery . 2006 (7S S)
  • [8] Growth Hormone, Glutamine, and an Optimal Diet Reduces Parenteral Nutrition in Patients With Short Bowel Syndrome: A Prospective, Randomized, Placebo-Controlled, Double-Blind Clinical Trial[J] . Theresa A. Byrne,Douglas W. Wilmore,Kishore Iyer,John Dibaise,Kerri Clancy,Malcolm K. Robinson,Peter Chang,Joseph M. Gertner,David Lautz.Annals of Surgery . 2005 (5)
  • [9] Low-dose growth hormone in adult home parenteral nutrition–dependent short bowel syndrome patients: A positive study[J] . David Seguy,Kouroche Vahedi,Nathalie Kapel,Jean–Claude Souberbielle,Bernard Messing.Gastroenterology . 2003 (2)
  • [10] The effectiveness of growth hormone, glutamine and a low-fat diet containing high-carbohydrate on the enhancement of the function of remnant intestine among patients with short bowel syndrome: a review of published trials
    Li-Ling
    Irving, M
    [J]. CLINICAL NUTRITION, 2001, 20 (03) : 199 - 204